characteristics.text: SAMN42157126
characteristics.characteristic: External Id
characteristics.text: Center for Biomedical AI, University Medical Center Hamburg
characteristics.characteristic: INSDC center name
characteristics.text: 2024-07-01T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2024-07-01T07:42:03.839Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS21837008
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS21837008
characteristics.characteristic: SRA accession
characteristics.text: FACS-sorted CD3+ cells
characteristics.characteristic: cell type
characteristics.text: 5.0.1
characteristics.characteristic: cellranger version
characteristics.text: missing
characteristics.characteristic: collection_date
characteristics.text: feature_reference_2.csv
characteristics.characteristic: feature reference
characteristics.text: missing
characteristics.characteristic: geo_loc_name
characteristics.text: mRNA+ADT+HTO
characteristics.characteristic: library type
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: refdata-gex-GRCh38-2020-A
characteristics.characteristic: reference genome
characteristics.text: Blood and Kidney
characteristics.characteristic: source_name
characteristics.text: Blood and Kidney
characteristics.characteristic: tissue
characteristics.text: T003BK, treatment, CD3+ cells, blood and kidney, GEX, ADT, HTO
characteristics.characteristic: title
characteristics.text: Ustekinumab (90 mg) in in combination with low-dose cyclophosphamide and steroids, following the RITUXVAS trial approach
characteristics.characteristic: treatment